SecBot SecBot
SECBOTREPLAY Home › Report › VRTX

VRTX · Officer files 144 for $8.4M sale

VERTEX PHARMACEUTICALS INC / MA · 144 filed Nov 12, 2026 at 10:23 ET

At the news

NEUTRALIMPACT 2/10

144 filed Nov 12, 2026 at 10:23 ET

Charles F. Wagner Jr., an officer of Vertex Pharmaceuticals, filed a Form 144 notice of intent to sell 15,286 shares of common stock, with an estimated market value of approximately $8.37 million based on the filing. The shares were acquired through ESPP purchases and restricted stock vesting between 2023 and 2025. The sale is scheduled for November 12, 2026.

  • Charles F. Wagner Jr., an officer of Vertex Pharmaceuticals, filed a Form 144 on November 12, 2026.
  • The filing indicates intent to sell 15,286 shares of common stock.
  • Estimated aggregate market value of the proposed sale is $8,374,740.82.
  • Shares were acquired through ESPP purchases and restricted stock vesting between November 2023 and May 2025.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access